You are here

  • Home
  • Archive
  • Volume 70, Issue 6
  • CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study

Article info

Article menu
Download PDFPDF
HIV related
CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study

Authors

  • Anna Grimsrud Division of Epidemiology and Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa PubMed articlesGoogle scholar articles
  • Morna Cornell Division of Epidemiology and Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa Centre for Infectious Disease Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa PubMed articlesGoogle scholar articles
  • Michael Schomaker Centre for Infectious Disease Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa PubMed articlesGoogle scholar articles
  • Matthew P Fox Center for Global Health & Development, Boston University, Boston, Massachusetts, USA Department of Internal Medicine, Faculty of Health Sciences, Health Economics and Epidemiology Research Office, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Catherine Orrell Faculty of Health Sciences, Desmond Tutu HIV Centre, Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa PubMed articlesGoogle scholar articles
  • Hans Prozesky Division of Infectious Diseases, Department of Medicine, University of Stellenbosch, Cape Town, South Africa Tygerberg Academic Hospital, Cape Town, South Africa PubMed articlesGoogle scholar articles
  • Kathryn Stinson Centre for Infectious Disease Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa Médecins Sans Frontières, Cape Town, South Africa PubMed articlesGoogle scholar articles
  • Frank Tanser Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa PubMed articlesGoogle scholar articles
  • Matthias Egger Division of International and Environmental Health, Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland PubMed articlesGoogle scholar articles
  • Landon Myer Division of Epidemiology and Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa Centre for Infectious Disease Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Anna Grimsrud, Division of Epidemiology & Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa; agrimsrud{at}gmail.com
View Full Text

Citation

Grimsrud A, Cornell M, Schomaker M for the International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration (IeDEA-SA), et al
CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study
J Epidemiol Community Health 2016;70:549-555.

Publication history

  • Received September 9, 2015
  • Accepted November 25, 2015
  • First published December 23, 2015.
Online issue publication 
May 11, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/